Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial

Delayed platelet engraftment (DPE) is associated with poor survival and increased transplantation‐related mortality after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Therefore, treatments are needed to improve platelet engraftment and prevent DPE. We performed a phase three, non‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Bingbing, Zhang, Xiaohan, Chen, Shiyu, Fan, Jingchao, Yang, Sitian, Cai, Yun, Wang, Pengcheng, Zhang, Qiaoxia, Gu, Qingli, Du, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790607/
https://www.ncbi.nlm.nih.gov/pubmed/35554955
http://dx.doi.org/10.1002/hon.3017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790607/
https://www.ncbi.nlm.nih.gov/pubmed/35554955
http://dx.doi.org/10.1002/hon.3017

Ejemplares similares